RxDoctor Payments Data

Joanna Blanco, MD

Internal Medicine · Harrington Park, NJNPI 1588018816

Payments from drug & device makers

$6,142in general payments, 2019–2025

Across 333 payments — averaging $18.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Novo Nordisk$679
  • Amgen$511
  • GSK$449
  • Pfizer$373
  • Boston Scientific$291
  • plus $3K from 49 others

What the payments were for

  • Food & beverage$6,142100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,142 in reported general payments places this provider in the 85th percentile of 4,032 internal medicine providers in New Jersey.

See all internal medicine providers in New Jersey

Medicare billing

Part B allowed, 2024
$200,278
Medicare patients
458
Services billed
2,849

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide102$130,298
JardianceEmpagliflozin91$79,923
EliquisApixaban135$67,600
OzempicSemaglutide47$55,660
ZenpepLipase/Protease/Amylase16$31,223
JanuviaSitagliptin Phosphate18$24,646
FarxigaDapagliflozin Propanediol18$20,157
MyrbetriqMirabegron18$19,642
LinzessLinaclotide16$18,607
XareltoRivaroxaban12$14,984
JanumetSitagliptin Phos/Metformin Hcl24$14,224
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr14$8,506
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog21$6,371
Fluticasone-SalmeterolFluticasone Propion/Salmeterol25$5,081
Atorvastatin Calcium445$5,026

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro$199$130,298102 claims
Boehringer IngelheimJardiance$86$79,92391 claims
PfizerEliquis$373$67,600135 claims
Novo NordiskOzempic$679$55,66047 claims
MerckJanuvia, Janumet$47$38,87042 claims
Aimmune Therapeutics, Inc.Zenpep$44$31,22316 claims
AbbVieLinzess, Synthroid$1,118$21,35656 claims
AstraZenecaFarxiga$93$20,15718 claims
Astellas Pharma US IncMyrbetriq$42$19,64218 claims
Johnson & JohnsonXarelto$68$14,98412 claims
GSKAnoro Ellipta$449$8,50614 claims
Amneal Pharmaceuticals LLCLevothyroxine Sodium$58$4,239362 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 4,032 internal medicine providers in New Jersey.

Other internal medicine in Harrington Park

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →